Latest Breaking News On - கிறிஸ் கிப்சன் - Page 4 : comparemela.com

SALT LAKE CITY Utah biotech startup Recursion Pharmaceuticals is upending the realm of clinical-stage drug research, melding robot-driven automation with digital artificial intelligence on a mission to revolutionize how new medications are developed to battle some of the rarest and most challenging of human medical conditions. And the company has been on an absolute tear in the last year, raising over $500 million via a public stock offering in April, expanding its footprint with a new research facility in Toronto and growing its staff by over 60%. It also has four medications currently in clinical trials. Recursion was founded in 2013 and outgrew two facilities at University of Utah s Research Park before taking over a 100,000-plus-square-foot space in downtown s Gateway center, the former home of Dick s Sporting Goods. This week, the company announced it will double the footprint of its flagship research and office facility, signing a lease on an additional 100,000 square feet

United statesNew yorkSalt lake cityMenlo parkUniversity of utahChris gibsonZavain darTina larsonUniversity of utah research parkDick sporting goodsRecursion pharmaceuticalsResearch parkChief operating officer tina larsonNew york cityLux capitalஒன்றுபட்டது மாநிலங்களில்